Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.64 |
| ▸ | MAOA | P21397 | 1/20 | 0.64 |
| ▸ | MMP3 | P08254 | 1/20 | 0.58 |
| ▸ | KIF11 | P52732 | 3/20 | 0.52 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | AHR | P35869 | 2/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15496905 | 1.00 | MAOB (0.64) | MAOBMAOAMMP3KIF11CA12 | |
| SCHEMBL15679888 | 0.93 | MAOB (0.57) | MAOBMAOAMMP3KIF11CA12 | |
| SCHEMBL154636 | 0.92 | — | — | |
| Water SCHEMBL27994834 | 0.92 | MAOB (0.73) | MAOBMAOAMMP3CA12CA2 | |
| Hydrochloric Acid SCHEMBL30722972 | 0.89 | MAOB (0.70) | MAOBMAOAMMP3CA12CA2 | |
| SCHEMBL6827721 | 0.89 | MAOB (0.70) | MAOBMAOAMMP3CA12CA2 | |
| SCHEMBL14656590 | 0.89 | MAOB (0.70) | MAOBMAOAMMP3CA12CA2 | |
| SCHEMBL25546197 | 0.87 | MAOB (0.52) | MAOBMAOAMMP3KIF11CA12 | |
| SCHEMBL13063633 | 0.86 | MMP3 (0.74) | MAOBMAOAMMP3KIF11CA12 | |
| SCHEMBL396846 | 0.86 | MMP3 (0.74) | MAOBMAOAMMP3KIF11CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108178737-B | 4 '- (4-bromonaphthalene-1-yl) [1, 1' -biphenyl ] -4-nitrile and synthesis method thereof | 河南省科学院化学研究所有限公司 | 2020-06-19 | — | — | CN | claimed |
| US-RE50748-E1 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2026-01-06 | — | — | US | disclosed |
| WO-2025121699-A1 | HETEROARYL AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 주식회사 랩토 | 2025-06-12 | — | — | WO | disclosed |
| WO-2025084253-A1 | CARBAZOLE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT | 保土谷化学工業株式会社 | 2025-04-24 | — | — | WO | disclosed |
| CN-113527330-B | Compound and application thereof | 北京鼎材科技有限公司 | 2024-05-24 | — | — | CN | disclosed |
| WO-2024086246-A2 | 2-SUBSTITUTED 3,4 A, 5, 7, 8, 8 A-HEXAHYDRO-4H-THIOP YRANO [4,3- DJPYRIMIDIN-4-ONES FOR WOUND TREATMENT | Eluciderm Inc. (US) | 2024-04-25 | — | — | WO | disclosed |
| CN-117836291-A | Cyano-substituted carbazole derivative and organic electroluminescent device comprising same | 株式会社乐普拓 | 2024-04-05 | — | — | CN | disclosed |
| CN-112745318-B | Compound and application thereof | 北京鼎材科技有限公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-112778300-B | Organic compound and organic electroluminescent device containing the same | 北京鼎材科技有限公司 | 2024-02-02 | — | — | CN | disclosed |
| US-20230320205-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-05 | — | — | US | disclosed |
| US-6306892-B1 | ENZYME INHIBITORS HETEROCYCLIC AMIDES | AGOURON PHARMACEUTICALS, INC. | 2001-10-23 | — | — | US | disclosed |
| US-6174915-B1 | FOR TREATING MAMMALIAN DISEASE CONDITION MEDIATED BY METALLOPROTEINASE ACTIVITY | AGOURON PHARMACEUTICALS, INC. | 2001-01-16 | — | — | US | disclosed |
| US-6008243-A | AN ENZYME INHIBITOR FOR PREVENTING THE DEGRADATION AND REMODELING OF CONNECTIVE TISSUES | AGOURON PHARMACEUTICALS, INC. (US) | 1999-12-28 | — | — | US | disclosed |
| EP-0937042-A1 | HETEROARYL SUCCINAMIDES AND THEIR USE AS METALLOPROTEINASE INHIBITORS | AGOURON PHARMACEUTICALS, INC. (US) | 1999-08-25 | — | — | EP | disclosed |
| WO-1998017643-A1 | HETEROARYL SUCCINAMIDES AND THEIR USE AS METALLOPROTEINASE INHIBITORS | AGOURON PHARMACEUTICALS, INC. (US) | 1998-04-30 | — | — | WO | disclosed |
| EP-0637624-B1 | Antiferroelectric liquid crystal compound | SHOWA SHELL SEKIYU (JP) | 1996-09-25 | — | — | EP | disclosed |
| US-5417885-A | Antiferroelectric liquid crystal compound | SHOWA SHELL SEKIYU KABUSHIKI KAISHA (JP) | 1995-05-23 | — | — | US | disclosed |
| EP-0637624-A1 | Antiferroelectric liquid crystal compound | Showa Shell Sekiyu Kabushiki Kaisha (JP) | 1995-02-08 | — | — | EP | disclosed |
| US-4309539-A | ELECTROOPTICS | HOFFMANN-LA ROCHE INC. (US) | 1982-01-05 | — | — | US | disclosed |
| US-4062798-A | NEMATIC CRYSTALS | HOFFMANN-LA ROCHE INC. (US) | 1977-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230320205-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS | NOM1, MNS1, NOS1 | MAOB 846/4885MAOA 779/4885MMP3 4715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.